MedTrace Logo

Controlled Trial Comparing the Performance of 22 Gauge Versus 25 Gauge EUS-FNA Needles (FNA-22G-25G)

NCT01016288 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2014-04-08

No results posted yet for this study

Summary

The aim of the study is to compare the performance characteristics of EUS-FNA 22 Gauge needle and EUS FNA 25 Gauge needle in terms of cellularity and diagnostic yield for diagnosis of various pathologies, including lymph nodes, pancreatic, luminal and other lesions outlined by EUS.

Conditions

  • Mediastinal Tumours and Lymph Nodes
  • Celiac, Perigastric and Peri-pancreatic Lymph Nodes
  • Pancreatic Masses
  • Liver Masses
  • Adrenal Masses

Sponsors & Collaborators

  • University of Medicine and Pharmacy Craiova

    collaborator OTHER

  • Allgemeines Krankenhaus Celle, Celle, Germany

    collaborator UNKNOWN

  • Pathologic Institute, Wittinger Strasse, Celle, Germany

    collaborator UNKNOWN

  • Sana Hospital Lübeck GmbH, Lübeck, Germany

    collaborator UNKNOWN

  • LungenClinic Grosshansdorf

    collaborator OTHER

  • University Hospital Schleswig-Holstein

    collaborator OTHER

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Principal Investigators

  • Peter Vilmann, Professor · Gentofte Hospital, Copenhagen University, Denmark

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-04-30
Completion
2012-12-31

Countries

  • Denmark
  • Germany
  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01016288 on ClinicalTrials.gov